Renal Histologic Analysis Provides Complementary Information to Kidney Function Measurement for Patients with Early Diabetic or Hypertensive Disease

Significance Statement CKD is defined by both functional changes (such as in eGFR and proteinuria) and renal histologic alterations. Although kidney function is acutely regulated, histologic changes such as interstitial fibrosis, tubular atrophy, and glomerulosclerosis could represent chronic damage, thus might provide additional information about disease severity. In an analysis of 859 kidney tissue samples, the authors found that the relationship between histologic changes and eGFR is not linear. At CKD stages 3–5, eGFR correlates with interstitial fibrosis/tubular atrophy and glomerulosclerosis reasonably well, whereas at earlier disease stages, eGFR poorly estimates histologic damage. Patients with diabetes, hypertension, or Black race had more severe histologic damage at the same eGFR. The inclusion of glomerulosclerosis significantly improved the kidney function decline estimation. Background Patients with diabetic or hypertensive kidney disease rarely undergo kidney biopsy because nephrologists commonly believe that biopsy-related risk outweighs the potential benefits of obtaining histologic information to guide clinical decisions. Although kidney function is acutely regulated, histologic changes such as interstitial fibrosis, tubular atrophy, and glomerulosclerosis may represent chronic kidney damage, and thus might provide additional information about disease severity. However, whether histologic analysis provides information complementary to clinically used kidney function measurements, such as eGFR and proteinuria, is unclear. Methods We performed a standardized semiquantitative histologic analysis of 859 nephrectomies obtained from individuals with or without diabetes mellitus or hypertension and varying degrees of kidney dysfunction. Changes in glomeruli, tubules, interstitium, and the vasculature were scored using 17 descriptive parameters in a standardized manner. We used multivariable linear and logistic regression analyses and unbiased, hierarchical clustering to assess associations between histologic alterations and clinical variables. Results At CKD stages 3–5, eGFR correlates reasonably well with the degree of glomerulosclerosis and interstitial fibrosis and tubular atrophy (IFTA). In patients with CKD stages 1–2, the degree of histologic damage was highly variable and eGFR poorly estimated the degree of damage. Individuals with diabetes mellitus, hypertension, or Black race had significantly more glomerulosclerosis and IFTA, at the same eGFR level. Inclusion of glomerulosclerosis improved the kidney function decline estimation, even at early disease stages. Conclusions Histologic analysis is an important complementary method for kidney disease evaluation, especially at early disease stages. Some individuals present with relatively severe structural damage despite preserved eGFR.

[1]  R. Townsend,et al.  The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort , 2021, Kidney international reports.

[2]  S. Waikar,et al.  Risk Factors for CKD Progression: Overview of Findings from the CRIC Study. , 2020, Clinical journal of the American Society of Nephrology : CJASN.

[3]  D. Leaf,et al.  Histopathologic Correlates of Kidney Function: Insights From Nephrectomy Specimens. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  David S Jones,et al.  Hidden in Plain Sight - Reconsidering the Use of Race Correction in Clinical Algorithms. , 2020, The New England journal of medicine.

[5]  B. Astor,et al.  Validation of the Kidney Failure Risk Equation in Kidney Transplant Recipients , 2020, Canadian journal of kidney health and disease.

[6]  Michael T. Eadon,et al.  Kidney Histopathology and Prediction of Kidney Failure: A Retrospective Cohort Study. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  A. Davenport,et al.  Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. , 2020, Kidney international.

[8]  David L. Birtwell,et al.  Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways. , 2020, Kidney international.

[9]  R. Townsend,et al.  Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study. , 2020, Kidney international.

[10]  Wei Yang,et al.  Reconsidering the Consequences of Using Race to Estimate Kidney Function. , 2019, JAMA.

[11]  K. Ohashi,et al.  Clinicopathological predictors for progression of chronic kidney disease in nephrosclerosis: a biopsy-based cohort study. , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  Z. Botta‐Dukát,et al.  Silhouette width using generalized mean—A flexible method for assessing clustering efficiency , 2018, bioRxiv.

[13]  Anand Srivastava,et al.  The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study. , 2018, Journal of the American Society of Nephrology : JASN.

[14]  M. Woodward,et al.  Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. , 2018, Kidney international.

[15]  J. Gaut,et al.  Renal Histopathologic Findings Associated With Severity of Clinical Acute Kidney Injury , 2018, The American journal of surgical pathology.

[16]  Chengxiang Qiu,et al.  Human Kidney Tubule-Specific Gene Expression Based Dissection of Chronic Kidney Disease Traits , 2017, EBioMedicine.

[17]  J. Roy,et al.  Analytic Considerations for Repeated Measures of eGFR in Cohort Studies of CKD. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[18]  Jai Radhakrishnan,et al.  A proposal for standardized grading of chronic changes in native kidney biopsy specimens. , 2017, Kidney international.

[19]  Yufeng Liu,et al.  Statistical significance for hierarchical clustering , 2014, Biometrics.

[20]  D. Rybin,et al.  Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts , 2016, American Journal of Nephrology.

[21]  A. Go,et al.  Inflammation and Progression of CKD: The CRIC Study. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[22]  S. Hewitt,et al.  Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital images , 2016, Modern Pathology.

[23]  M. Breyer,et al.  The next generation of therapeutics for chronic kidney disease , 2016, Nature Reviews Drug Discovery.

[24]  M. Rudnicki,et al.  A 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseases , 2014, BMC Medical Genomics.

[25]  J. Coresh,et al.  Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. , 2014, JAMA.

[26]  Katalin Susztak,et al.  Molecular mechanisms of diabetic kidney disease. , 2014, The Journal of clinical investigation.

[27]  N. Tangri,et al.  A predictive model for progression of chronic kidney disease to kidney failure. , 2011, JAMA.

[28]  J. Stockman,et al.  A New Equation to Estimate Glomerular Filtration Rate , 2011 .

[29]  Paul A Murtaugh,et al.  Performance of several variable-selection methods applied to real ecological data. , 2009, Ecology letters.

[30]  Fernand,et al.  The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. , 2009, Kidney international.

[31]  Samy Suissa,et al.  Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.

[32]  M. Nangaku Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. , 2005, Journal of the American Society of Nephrology : JASN.

[33]  T. Meyer,et al.  Podocyte loss and progressive glomerular injury in type II diabetes. , 1997, The Journal of clinical investigation.

[34]  K. Nath,et al.  Tubulointerstitial changes as a major determinant in the progression of renal damage. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  N. Duan Smearing Estimate: A Nonparametric Retransformation Method , 1983 .